E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 7/27/2006 in the Prospect News Biotech Daily.

PRA on hold by Jefferies

Jefferies & Co., Inc. analyst David Windley maintained PRA International at a hold rating with a lower price target of $23 on management's confidence that the second half of 2006 will show improvement. PRA reported second-quarter results including $0.28 per share on $70.1 million in revenue, compared to Jefferies' estimate of $0.28 on $74.1 million and consensus of $0.28 on $73.3 million. Management raised 2006 revenue guidance to $300 million to $320 million from the $290 million to $300 million range. Shares of the Reston, Va.-based contract research organization were down 78 cents, or 3.39%, at $22.22 on volume of 171,238 shares versus the three-month running average of 248,034 shares. (Nasdaq: PRAI)


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.